Rosuvastatin is cost-effective in treating patients to low-density lipoprotein-cholesterol goals compared with atorvastatin, pravastatin and simvastatin: analysis of the STELLAR trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples